Longitudinal changes in inflammatory biomarkers among patients with COVID-19: A nationwide study in Iceland.

ABSTRACT:

Objectives

All SARS-CoV-2-positive persons in Iceland were prospectively monitored and those who required outpatient evaluation or were admitted to hospital underwent protocolized evaluation that included a standardized panel of biomarkers. The aim was to describe longitudinal changes in inflammatory biomarkers throughout the infection period of patients with COVID-19 requiring different levels of care.

Design

Registry-based study.

Setting

Nationwide study in Iceland.

Patients

All individuals who tested positive for SARS-CoV-2 by real-time polymerase chain reaction (RT-PCR) from February 28 to December 31, 2020 in Iceland and had undergone blood tests between 5 days before and 21 days following onset of symptoms.

Measurements and main results

Data were c

SUBMITTER: Oskarsdottir T 

PROVIDER: S-EPMC9350372 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature